| Name | Title | Contact Details |
|---|---|---|
Christopher Smith |
Director of Information Security - Facilities - and Governance Compliance | Profile |
Relmada Therapeutics, Inc. is a clinical stage, private biopharmaceutical company with a diversified portfolio of four products and a deep early stage pipeline for the treatment of pain. Relmada’s strategy focuses on two complementary pillars: the improvement of proven drug candidates with novel delivery methods and pharmaceutical compositions and the development of d-methadone as an innovative NMDA (N-Methyl-D-aspartate) inhibitor platform. The Company is currently developing several drug candidates including: LevoCap ER, its abuse resistant, once–a-day sustained release dosage form of the opioid analgesic levorphanol; d-methadone, the NDMA receptor antagonist for diabetic painful neuropathy (DPN); BuCap, its oral dosage form of the opioid analgesic buprenorphine; MepiGel, its FDA Orphan Drug designated topical formulation of the local anesthetic mepivacaine.
Pinsonault Associates is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Flanders, NJ. To find more information about Pinsonault Associates, please visit www.pinsonault.com
Aquor Health Care Svc is a Woodbridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Absolute Resource Solutions is a Flanders, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedSynergies partners with health care organizations and physicians to align their operations by providing revenue cycle management, practice management, consulting services, business process analysis and software integration solutions.